OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
May 03, 2023
The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.
E&L analytical testing methods can be determined through pointed consideration of the differences small- and large-molecule drug products.
April 28, 2023
clonoSEQ Assay is authorized by FDA for MRD assessment in lymphoid malignancies and is highly accurate, sensitive, and standardized compared to other technologies used for disease burden assessment.
April 25, 2023
Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.
April 24, 2023
BioChain has reached partnerships with NanoString and 10x Genomics to extend its spatial multiomics services.
JMI Laboratories and bioMérieux will work to improve microbiology diagnostics tools.
April 12, 2023
The BalanCD CHO media portfolio is designed to ensure maximized growth, viability, and productivity of CHO cell lines.
April 07, 2023
Lonza and ABL Bio are collaborating on the development and manufacture of bispecific antibody product.